I'm Chief Executive Officer of Ionis and Board Director at Ionis, and I couldn't be more thrilled to provide an update on the remarkable progress we have made at Ionis to drive accelerating value for ...
The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for ...
The fair value estimate for Ionis Pharmaceuticals has shifted from US$96.73 to US$100.92, a modest reset that puts fresh numbers around the stock. This move comes during an active period of Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results